Cultivarium Announces Collaboration with ATCC to Expand Repertoire of Microbes Available for the Bioeconomy
Cultivarium and ATCC have entered a multi-phase research collaboration to expand the use of non-model microorganisms.
Uncategorized
HUIDAGENE ANNOUNCES IND APPROVAL OF THE FIRST CHINA MULTI-REGIONAL, MULTI-NATIONAL MASTER PROTOCOL OF HG004 BY NMPA
HuidaGene Therapeutics announces that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has approved its investigational new drug (IND) application for the planned multi-regional, multi-national clinical trial of HG004.
Phio Pharmaceuticals Presents Preclinical Data Demonstrating Synergy-Enhanced in vivo Anti-Tumor Efficacy of PD-1/CTLA-4 Dual-Targeting INTASYL
Phio Pharmaceuticals Corp. today announced that in vivo data from a mouse model of colon cancer demonstrates target synergy-enhanced anti-tumor efficacy from a novel dual-targeting mouse PD-1 and CTLA-4 of an INTASYL coformulation.
Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics
Coeptis Therapeutics Holdings, Inc. announced it has entered into a binding term sheet with Deverra Therapeutics, Inc. (“Deverra Therapeutics”) pursuant to which it has obtained an exclusive right, until August 31, 2023.
Pre-Clinical Data of Palatin’s Melanocortin Agonist Demonstrating Therapeutic Effects in Diabetic Retinopathy and Uveitis Published in the International Journal of Molecular Sciences
Palatin Technologies, Inc. today announced The International Journal of Molecular Sciences published a manuscript, “Stimulating the Melanocortin System in Uveitis and Diabetes Preserves the Structure and Anti-Inflammatory Activity of the Retina” by Tat Fong Ng and Andrew W. Taylor from Department of Ophthalmology, Boston University Chobanian and Avedisian School of Medicine, in Boston, Massachusetts.
Ampio Pharmaceuticals Issues Letter to Stockholders – April 18, 2023
Ampio Pharmaceuticals, Inc. released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.
Ampio Pharmaceuticals Issues Letter to Stockholders – April 18, 2023 Read More »
Cincuenta vuelos del dron Ingenuity en Marte
El helicóptero robótico Ingenuity de la NASA ha efectuado su vuelo número 50 en Marte. El Ingenuity, que es la primera aeronave en volar en otro mundo, realizó ese vuelo número 50 el 13 de abril, recorriendo más de 322,2 metros en 145,7 segundos. El …
Ondine Biomedical’s Nasal Photodisinfection Cuts Surgical Site Infections by 66%
Ondine Biomedical Inc. presented detailed results from its US Phase 2 BENEFIT-aPDT clinical trial to the 33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark.
Ondine Biomedical’s Nasal Photodisinfection Cuts Surgical Site Infections by 66% Read More »
Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database
Nordic Nanovector ASA announces that full results from its Phase 2 clinical trials of Betalutin® in resistant/refractory indolent non-Hodgkin’s lymphoma have been published at EudraCT, the European Union Drug Regulating Authorities Clinical Trials Database of the European Union.
La sonda espacial Lucy observa de lejos asteroides que visitará
Algunos de los asteroides que Lucy visitará se encuentran aún a más de 530 millones de kilómetros de la nave espacial, lo que supone más del triple de la distancia media entre la Tierra y el Sol. Pero a pesar de la gran distancia y de los tamaños peque&ntild …
La sonda espacial Lucy observa de lejos asteroides que visitará Read More »